{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:18:30Z","timestamp":1762604310655,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":26,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071625040"},{"type":"electronic","value":"9781071625057"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2505-7_9","type":"book-chapter","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T11:04:18Z","timestamp":1654599858000},"page":"121-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Liposomal siRNA Delivery in Papillary Thyroid Carcinoma Cells"],"prefix":"10.1007","author":[{"given":"Farhadul","family":"Islam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-1-4939-7734-5_23","volume":"1756","author":"F Islam","year":"2018","unstructured":"Islam F, Gopalan V, Lam AK (2018) RNA interference-mediated gene silencing in esophageal adenocarcinoma. Methods Mol Biol 1756:269\u2013279","journal-title":"Methods Mol Biol"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.3390\/cancers12113159","volume":"12","author":"PK Das","year":"2020","unstructured":"Das PK, Asha SY, Abe I, Islam F, Lam AK (2020) Roles of non-coding RNAs on anaplastic thyroid carcinomas. Cancers (Basel) 12:3159","journal-title":"Cancers (Basel)"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/978-1-4939-2291-8_25","volume":"1269","author":"A Lagan\u00e0","year":"2015","unstructured":"Lagan\u00e0 A, Veneziano D, Russo F, Pulvirenti A, Giugno R, Croce CM, Ferro A (2015) Computational design of artificial RNA molecules for gene regulation. Methods Mol Biol 1269:393\u2013412","journal-title":"Methods Mol Biol"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","volume":"65","author":"CN Landen Jr","year":"2005","unstructured":"Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G, Sood AK (2005) Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res 65:6910\u20136918","journal-title":"Cancer Res"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.1523\/JNEUROSCI.3183-05.2005","volume":"25","author":"M D\u00edaz-Hern\u00e1ndez","year":"2005","unstructured":"D\u00edaz-Hern\u00e1ndez M, Torres-Peraza J, Salvatori-Abarca A, Mor\u00e1n MA, G\u00f3mez-Ramos P, Alberch J, Lucas JJ (2005) Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington\u2019s disease. J Neurosci 25:9773\u20139781","journal-title":"J Neurosci"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1525-0016(03)00244-2","volume":"8","author":"H Giladi","year":"2003","unstructured":"Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum O, Galun E (2003) Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 8:769\u2013776","journal-title":"Mol Ther"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-59745-237-3_10","volume":"433","author":"KK Ewert","year":"2008","unstructured":"Ewert KK, Ahmad A, Bouxsein NF, Evans HM, Safinya CR (2008) Non-viral gene delivery with cationic liposome-DNA complexes. Methods Mol Biol 433:159\u2013175","journal-title":"Methods Mol Biol"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"8230","DOI":"10.1158\/1078-0432.CCR-05-1895","volume":"11","author":"WC Zamboni","year":"2005","unstructured":"Zamboni WC (2005) Liposomal, nanoparticle, and conjugated formulations of anticancer agents. Clin Cancer Res 11:8230\u20138234","journal-title":"Clin Cancer Res"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1211\/002235702928","volume":"55","author":"JK Kim","year":"2003","unstructured":"Kim JK, Choi SH, Kim CO, Park JS, Ahn WS, Kim CK (2003) Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency. J Pharm Pharmacol 55:453\u2013460","journal-title":"J Pharm Pharmacol"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i3.10","volume":"19","author":"P Opanasopit","year":"2002","unstructured":"Opanasopit P, Nishikawa M, Hashida M (2002) Factors affecting drug and gene delivery: effects of interaction with blood components. Crit Rev Ther Drug Carrier Syst 19:191\u2013233","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.rinphs.2011.08.001","volume":"1","author":"T Gjetting","year":"2011","unstructured":"Gjetting T, Andresen TL, Christensen CL, Cramer F, Poulsen TT, Poulsen HS (2011) A simple protocol for preparation of a liposomal vesicle with encapsulated plasmid DNA that mediate high accumulation and reporter gene activity in tumor tissue. Results Pharma Sci 1:49\u201356","journal-title":"Results Pharma Sci"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11095-006-9180-5","volume":"24","author":"W Li","year":"2007","unstructured":"Li W, Szoka FC Jr (2007) Lipid-based nanoparticles for nucleic acid delivery. Pharm Res 24:438\u2013449","journal-title":"Pharm Res"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2174\/156720105774370159","volume":"2","author":"P Sapra","year":"2005","unstructured":"Sapra P, Tyagi P, Allen TM (2005) Ligand-targeted liposomes for cancer treatment. Curr Drug Deliv 2:369\u2013381","journal-title":"Curr Drug Deliv"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.biopha.2004.01.003","volume":"58","author":"E Wagner","year":"2004","unstructured":"Wagner E, Kircheis R, Walker GF (2004) Targeted nucleic acid delivery into tumors: new avenues for cancer therapy. Biomed Pharmacother 58:152\u2013161","journal-title":"Biomed Pharmacother"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","volume":"42","author":"A Gabizon","year":"2003","unstructured":"Gabizon A, Shmeeda H, Barenholz Y (2003) Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin Pharmacokinet 42:419\u2013436","journal-title":"Clin Pharmacokinet"},{"key":"9_CR16","first-page":"987","volume":"54","author":"A Gabizon","year":"1994","unstructured":"Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A, Barenholz Y (1994) Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54:987\u2013992","journal-title":"Cancer Res"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1021\/mp060039w","volume":"3","author":"SD Li","year":"2006","unstructured":"Li SD, Huang L (2006) Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. Mol Pharm 3:579\u2013588","journal-title":"Mol Pharm"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0005-2736(99)00209-6","volume":"1463","author":"DD Stuart","year":"2000","unstructured":"Stuart DD, Allen TM (2000) A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability. Biochim Biophys Acta 1463:219\u2013229","journal-title":"Biochim Biophys Acta"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/sj.gt.3300821","volume":"6","author":"JJ Wheeler","year":"1999","unstructured":"Wheeler JJ, Palmer L, Ossanlou M, MacLachlan I, Graham RW, Zhang YP, Hope MJ, Scherrer P, Cullis PR (1999) Stabilized plasmid-lipid particles: construction and characterization. Gene Ther 6:271\u2013281","journal-title":"Gene Ther"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/S0006-3495(01)76202-9","volume":"80","author":"N Maurer","year":"2001","unstructured":"Maurer N, Wong KF, Stark H, Louie L, McIntosh D, Wong T, Scherrer P, Semple SC, Cullis PR (2001) Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes. Biophys J 80:2310\u20132326","journal-title":"Biophys J"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s11095-004-1873-z","volume":"22","author":"LB Jeffs","year":"2005","unstructured":"Jeffs LB, Palmer LR, Ambegia EG, Giesbrecht C, Ewanick S, MacLachlan I (2005) A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA. Pharm Res 22:362\u2013372","journal-title":"Pharm Res"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/jps.20055","volume":"93","author":"C Li","year":"2004","unstructured":"Li C, Deng Y (2004) A novel method for the preparation of liposomes: freeze drying of monophase solutions. J Pharm Sci 93:1403\u20131414","journal-title":"J Pharm Sci"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/abbi.1997.0385","volume":"348","author":"TJ Anchordoquy","year":"1997","unstructured":"Anchordoquy TJ, Carpenter JF, Kroll DJ (1997) Maintenance of transfection rates and physical characterization of lipid\/DNA complexes after freeze-drying and rehydration. Arch Biochem Biophys 348:199\u2013206","journal-title":"Arch Biochem Biophys"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11095-008-9766-1","volume":"26","author":"SY Wu","year":"2009","unstructured":"Wu SY, Putral LN, Liang M, Chang HI, Davies NM, McMillan NA (2009) Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use. Pharm Res 26:512\u2013522","journal-title":"Pharm Res"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/cells7120265","volume":"7","author":"H Maroof","year":"2018","unstructured":"Maroof H, Islam F, Dong L, Ajjikuttira P, Gopalan V, McMillan NAJ, Lam AK (2018) Liposomal delivery of miR-34b-5p induced cancer cell death in thyroid carcinoma. Cell 7:265","journal-title":"Cell"},{"key":"9_CR26","first-page":"5562","volume":"22","author":"XB Gao","year":"2018","unstructured":"Gao XB, Chen CL, Tian ZL, Yuan FK, Jia GL (2018) MicroRNA-791 is an independent prognostic factor of papillary thyroid carcinoma and inhibits the proliferation of PTC cells. Eur Rev Med Pharmacol Sci 22:5562\u20135568","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Methods in Molecular Biology","Papillary Thyroid Carcinoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2505-7_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T23:12:45Z","timestamp":1654643565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2505-7_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071625040","9781071625057"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2505-7_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"8 June 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}